Literature DB >> 31630167

Infant Respiratory Syncytial Virus Bronchiolitis and Subsequent Risk of Pneumonia, Otitis Media, and Antibiotic Utilization.

Andrew Abreo1, Pingsheng Wu1,2, Brittney M Donovan1, Tan Ding2, Tebeb Gebretsadik2, Xiang Huang1, Cosby A Stone1, Kedir N Turi1, Tina V Hartert1.   

Abstract

Infant respiratory syncytial virus (RSV) bronchiolitis in the first 6 months of life was associated with increased odds of pneumonia, otitis media, and antibiotic prescription fills in the second 6 months of life. These data suggest a potential value of future RSV vaccination programs on subsequent respiratory health.
© The Author(s) 2019. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  bronchiolitis; infant antibiotics; otitis media; pneumonia; respiratory syncytial virus

Year:  2020        PMID： 31630167      PMCID： PMC7312311          DOI： 10.1093/cid/ciz1033

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  12 in total

Review 1.  Viral bacterial co-infection of the respiratory tract during early childhood.

Authors:  Jaelle C Brealey; Peter D Sly; Paul R Young; Keith J Chappell
Journal:  FEMS Microbiol Lett       Date:  2015-04-15       Impact factor: 2.742

2.  Respiratory illness after severe respiratory syncytial virus disease in infancy in The Gambia.

Authors:  M W Weber; P Milligan; B Giadom; M A Pate; A Kwara; A D Sadiq; M Chanayireh; H Whittle; B M Greenwood; K Mulholland
Journal:  J Pediatr       Date:  1999-12       Impact factor: 4.406

3.  Recent trends in outpatient antibiotic use in children.

Authors:  Louise Elaine Vaz; Kenneth P Kleinman; Marsha A Raebel; James D Nordin; Matthew D Lakoma; M Maya Dutta-Linn; Jonathan A Finkelstein
Journal:  Pediatrics       Date:  2014-02-02       Impact factor: 7.124

4.  Rates of hospitalization for respiratory syncytial virus infection among children in medicaid.

Authors:  T G Boyce; B G Mellen; E F Mitchel; P F Wright; M R Griffin
Journal:  J Pediatr       Date:  2000-12       Impact factor: 4.406

5.  Reduction of respiratory syncytial virus hospitalization among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis. The PREVENT Study Group.

Authors: 
Journal:  Pediatrics       Date:  1997-01       Impact factor: 7.124

Review 6.  Protective and Harmful Immunity to RSV Infection.

Authors:  Peter J M Openshaw; Chris Chiu; Fiona J Culley; Cecilia Johansson
Journal:  Annu Rev Immunol       Date:  2017-02-06       Impact factor: 28.527

7.  Increased prevalence of otitis media following respiratory syncytial virus infection.

Authors:  S Kristjánsson; H E Skúladóttir; M Sturludóttir; G Wennergren
Journal:  Acta Paediatr       Date:  2009-12-11       Impact factor: 2.299

8.  Accuracy of physician billing claims for identifying acute respiratory infections in primary care.

Authors:  Geneviève Cadieux; Robyn Tamblyn
Journal:  Health Serv Res       Date:  2008-07-28       Impact factor: 3.402

9.  Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.

Authors:  Julian P Legg; Imran R Hussain; Jill A Warner; Sebastian L Johnston; John O Warner
Journal:  Am J Respir Crit Care Med       Date:  2003-05-28       Impact factor: 21.405

10.  Otitis and respiratory distress episodes following a respiratory syncytial virus infection.

Authors:  D A Kafetzis; H Astra; M Tsolia; G Liapi; J Mathioudakis; K Kallergi
Journal:  Clin Microbiol Infect       Date:  2003-10       Impact factor: 8.067
View more
  4 in total

Review 1.  Recent advances in development of nano-carriers for immunogene therapy in various complex disorders.

Authors:  Sanaz Shahgordi; Fatemeh Oroojalian; Ezzat Hashemi; Maryam Hashemi
Journal:  Iran J Basic Med Sci       Date:  2022-02       Impact factor: 2.532

2.  Performance evaluation of antibody tests for detecting infant respiratory syncytial virus infection.

Authors:  Samadhan J Jadhao; Binh Ha; Courtney McCracken; Tebeb Gebretsadik; Christian Rosas-Salazar; James Chappell; Suman Das; Tina Hartert; Larry J Anderson
Journal:  J Med Virol       Date:  2020-12-29       Impact factor: 20.693

3.  The impact of maternal RSV vaccine to protect infants in Gavi-supported countries: Estimates from two models.

Authors:  Ranju Baral; Xiao Li; Lander Willem; Marina Antillon; Alba Vilajeliu; Mark Jit; Philippe Beutels; Clint Pecenka
Journal:  Vaccine       Date:  2020-06-22       Impact factor: 3.641

4.  The effectiveness and safety of Tanreqing Injection combined with ganciclovir on the treatment of respiratory syncytial virus pneumonia in children: A protocol for systematic review and meta-analysis of randomized controlled trials.

Authors:  Wei-Jun Zhu; Xuan Zhou; Juan Cao; Yu Shi
Journal:  Medicine (Baltimore)       Date:  2020-09-18       Impact factor: 1.817
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.